About this trial
This study aims to evaluate the efficacy of interlaminar steroid injections at treating pain in lumbar radiculopathy at varying doses, to evaluate the efficacy of interlaminar steroid injections at improving quality of life and function in lumbar radiculopathy at varying doses, and to evaluate difference in efficacy between triamcinolone and dexamethasone interlaminar steroid injections at treating pain in lumbar radiculopathy at varying doses, with the overarching hypotheses that there is no difference in reported pain reduction, quality of life, or function among patients receiving low, moderate, or high doses, and no difference in reported pain reduction between triamcinolone and dexamethasone.
Eligibility criteria
Qualifiers
Adults able to consent
Lumbar radiculopathy with MRI-confirmed pathology
No history of back surgery
Use of interlaminar approach lumbar spine injections
Disqualifiers
Adults unable to consent
Individuals who are not yet adults (infants, children, teenagers)
Pregnant women
History of back surgery
Trial design
Treatments tested in this trial
- Triamcinolone 10 Mg/mL Injectable Suspension
- Triamcinolone 40 Mg/mL Injectable Suspension
- Triamcinolone 80 Mg/mL Injectable Suspension
- Dexamethasone 2 MG
- Dexamethasone 4mg
- Dexamethasone 8 MG
Treatment groups
6
Treatment groupsSee each treatment group below.